Glenmark Pharmaceuticals.
Indian multinational pharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 33
What's happening
Earlier this month
-
Glenmark Pharmaceuticals launched a product in Brazil after receiving regulatory approval from ANVISA, also noting US approval.Some support3 reports
-
Glenmark Pharmaceuticals and South Piedmont Community College announced a partnership focusing on pharmaceutical manufacturing workforce development in North Carolina.Some support1 report
-
Stock targets indicate strong buying trend for Laurus Labs and Glenmark Pharmaceuticals.Some support1 report
One to three months ago
-
Glenmark Pharmaceuticals is seeking marketing authorization for its products in key European markets.Some support1 report1 development inside
-
Glenmark launched an equivalent drug to Merck's BRIDION.Some support2 reports
-
Glenmark Pharmaceuticals is being investigated for allegedly conspiring with competitors, including Apotex, to fix generic drug prices.Some support1 report
Gone quiet
No new reports in 90+ days-
The European Commission granted marketing authorization for Winlevi, a product manufactured by Glenmark Pharmaceuticals, on June 1, 2026.Some support1 report
-
AbbVie and Glenmark Pharmaceuticals are noted as leading players in the nocturia market, driven by geriatric population shifts.Speculative1 report
No events began in the chosen period. Widen it, or reset.
Around Glenmark Pharmaceuticals this week
News at the entities that move Glenmark Pharmaceuticals most-
European Commission StructuralA European Commission summit focused on strategic cooperation, minerals, and pivoting away from the United States toward the EU.Moves Glenmark Pharmaceuticals
-
North Carolina StructuralMatthew Rutter attended a convention held in North Carolina on June 19, 2026.Moves Glenmark Pharmaceuticals
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Glenmark Pharmaceuticals
-
Apotex OperationalA settlement involving drug manufacturers was announced by Andy Wilson after the U.S. District Court for Connecticut approved the plan.Moves Glenmark Pharmaceuticals
-
company StructuralBoard approved a quarterly cash dividend increase on August 1, 2026.Moves Glenmark Pharmaceuticals
-
North America Shared contextAn inaugural rodeo was held in Cape Breton, featuring athletes who represented North America.Moves Glenmark Pharmaceuticals
Connections
The 12 strongest of 33, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
company Structural
Glenmark Pharmaceuticals is the parent company of the entity known as 'company', which operates as a wholly-owned subsidiary.
-
European Commission Structural
Glenmark seeks market authorization from the European Commission for product launch.
-
North Carolina Structural
North Carolina is investigating Glenmark Pharmaceuticals regarding generic drug price-fixing, while the company operates a manufacturing facility in the state.
-
Merck Sharp & Dohme Operational
The two companies are in direct market competition, evidenced by Glenmark launching a drug equivalent to Merck's BRIDION.
-
FDA Structural
The FDA acts as the formal regulatory body responsible for approving products relevant to Glenmark Pharmaceuticals.
-
Brazilian Health Regulatory Agency Structural
The company operates under the formal oversight and product approval requirements of the Brazilian health regulatory agency.
-
Apotex Operational
Apotex and Glenmark Pharmaceuticals are alleged to have conspired to fix prices with competitors.
-
South Piedmont Community College Operational
Glenmark Pharmaceuticals and South Piedmont Community College maintain a partnership focused on pharmaceutical manufacturing workforce development.
Show all 12 connections
-
North America Shared context
Glenmark Pharmaceuticals operates and launches products within the North American market.
-
Mumbai Shared context
Glenmark Pharmaceuticals utilizes Mumbai as a location for industry symposiums and events.
-
Europe Shared context
Glenmark Pharmaceuticals is actively launching products within key European markets.
-
Donald Trump Shared context
The relationship is contextual, as proposed tariffs associated with Donald Trump are noted to affect the generic drug manufacturing sector.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
1 eventJuly 2026
2 eventsShow 1 earlier month
June 2026
3 events- Glenmark Pharmaceuticals is seeking marketing authorization for its products in key European markets.
- The European Commission granted marketing authorization for Winlevi, a product manufactured by Glenmark Pharmaceuticals, on June 1, 2026.
- AbbVie and Glenmark Pharmaceuticals are noted as leading players in the nocturia market, driven by geriatric population shifts.